Smartwatches and rings that claim to measure blood sugar levels for medical purposes without piercing the skin could be dangerous and should be avoided, the U.S. Food and Drug Administration warned Wednesday.
Feb 22, 2024
0
1
Women in menopause, men with low testosterone, and adults transitioning genders all sometimes see doctors about hormone therapy. But personally tailored hormone treatments may not be better, or safer, than standard Food and ...
Jul 8, 2020
0
1
(HealthDay)—The U.S. approval and regulation processes for pharmaceutical agents have evolved during the last four decades, according to a study published in the Jan. 14 issue of the Journal of the American Medical Association.
Jan 15, 2020
0
0
A critical shortage of generic drugs in the United States, particularly in cancer care, could be curbed with legislation now being hammered out by the US House and Senate, doctors said on Monday.
Jun 4, 2012
0
0
Dr. Anglea Wandinger-Ness and Dr. Laurie Hudson were awarded a Provocative Questions grant to investigate the use of R-ketorolac against ovarian cancer. Ketorolac is an NSAID that the FDA approved for human use in 1991. They ...
Sep 27, 2012
0
0
The U.S. Food and Drug Administration (FDA) recently approved aducanumab, the first treatment that aims to slow the progression of Alzheimer's disease. But approval of the drug has provoked mixed reactions from the scientific ...
Jun 16, 2021
0
5
Following two decades of research on a group of rare diseases called hypereosinophilic syndrome at Cincinnati Children's Hospital Medical Center, the U.S. Food and Drug Administration has approved the drug Nucala (mepolizumab) ...
Sep 28, 2020
0
3
A closely watched experimental drug for Lou Gehrig's disease got an unusual second look from U.S. regulators on Wednesday, following intense pressure to approve the treatment for those with the fatal illness.
Sep 7, 2022
0
4
US health authorities on Tuesday issued a warning to the maker of a new inhalable caffeine product sold in the United States and France, citing mislabeling and safety concerns.
Mar 6, 2012
1
0
The U.S. Food and Drug Administration's recent approval of aducanumab, a treatment for Alzheimer's disease, has drawn decidedly mixed reviews.
Jun 21, 2021
0
2
